C. Fadul

Mark D Anderson, Jennie W. Taylor, Mark D. Anderson, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anti-N-methyl-D-aspartate receptor encephalitis: a patient with refractory illness after 25 months of intensive immunotherapy.

A. Schned, C. Fadul, J. Dalmau, 2013, JAMA neurology.

Acknowledgement of Reviewers 2012

Steven D Chang, A. Friedman, D. Brat, 2013, Dysphagia (New York. Print).

Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.

D. Gladstone, D. Roberts, A. Paravati, 2013, International journal of radiation oncology, biology, physics.

Phase II study of dose-intense temozolomide in recurrent glioblastoma.

R. Beroukhim, P. Wen, A. Norden, 2011, Journal of Clinical Oncology.

The landscape of brain tumor mimics in neuro-oncology practice

Sohil H. Patel, C. Fadul, B. Purow, 2022, Journal of Neuro-Oncology.

Neurological and neurosurgical approaches in the management of malignant brain tumours

C. Fadul, J. Posner, W. Shapiro, 1987 .

Management of newly diagnosed glioblastoma: guidelines development, value and application

D. Brat, J. Olson, T. Ryken, 2009, Journal of Neuro-Oncology.

Fluid attenuation in non‐contrast‐enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma

Sohil H. Patel, R. Jain, D. Schiff, 2021, Journal of Neuro-Oncology.

Checkpoint inhibitor failure in hypermutated and mismatch repair-mutated recurrent high-grade gliomas.

D. Schiff, C. Fadul, B. Purow, 2019, Neuro-oncology practice.

Antitumour effects of temozolomide in a man with a large, invasive prolactin‐producing pituitary neoplasm

K. Kovacs, C. Fadul, É. Horváth, 2006, Clinical endocrinology.

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

J. Olson, P. Wen, C. Fadul, 2008, Journal of Neuro-Oncology.

Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiforme

J. Olson, P. Wen, C. Fadul, 2008, Journal of Neuro-Oncology.

Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy

H. Wishart, T. Tosteson, J. Gui, 2011, Journal of immunotherapy.

Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme.

J. Gui, J. Fisher, M. Ernstoff, 2011, Neuro-oncology.

Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma

N. Wages, C. Slingluff, C. Fadul, 2021, Cells.

A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma

Gregory P. Way, Robert J. Allaway, C. Greene, 2016, bioRxiv.

Phase 2 study of dose-intense temozolomide in recurrent glioblastoma.

Katrina H. Smith, R. Beroukhim, P. Wen, 2013, Neuro-oncology.

Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma

A. Gaur, M. Israel, C. Fadul, 2013, PloS one.

Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial

Jeffrey A. Cohen, E. Stommel, C. Fadul, 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

MRI features predict tumor grade in isocitrate dehydrogenase (IDH)–mutant astrocytoma and oligodendroglioma

David A. Joyner, Sohil H. Patel, R. Jain, 2022, Neuroradiology.

Features of diffuse gliomas that are misdiagnosed on initial neuroimaging: a case control study

R. Jain, D. Schiff, C. Fadul, 2018, Journal of Neuro-Oncology.

Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literature

J. Biegel, C. Fadul, Jonathan P. Park, 2007, Journal of Neuro-Oncology.

Immunotherapy for the Treatment of Glioblastoma

M. Ernstoff, C. Fadul, Alissa A. Thomas, 2012, Cancer journal.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

C. Shapiro, C. Fadul, E. Paskett, 2013, JAMA.

Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases

C. Fadul, Enrico C Lallana, Camilo E Fadul, 2011, Current neuropharmacology.

Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center.

Gregory J Tsongalis, Jason D Peterson, Xiaoying Liu, 2015, The oncologist.

Oligodendroglioma confers higher risk of radiation necrosis

Sohil H. Patel, D. Schiff, C. Fadul, 2019, Journal of Neuro-Oncology.

Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

C. Eskey, C. Fadul, N. Simmons, 2006, Journal of neurosurgery.

Genetics of glioblastoma: a window into its imaging and histopathologic variability.

Keith Paulsen, David W Roberts, Cong Ran, 2011, Radiographics : a review publication of the Radiological Society of North America, Inc.

Chapter 12 – Management of Primary Central Nervous System Lymphomas

C. Fadul, P. Ely, 2012 .

Stereotactic radiosurgery with and without checkpoint inhibition for patients with metastatic non-small cell lung cancer to the brain: a matched cohort study.

L. Hansen, J. Sheehan, C. Fadul, 2020, Journal of neurosurgery.

Morbidity and mortality of craniotomy for excision of supratentorial gliomas

H. Thaler, C. Fadul, J. Posner, 1988, Neurology.

Cytotoxic Chemotherapy and Targeted Therapy for Aggressive Pituitary Tumors

C. Fadul, Alissa A. Thomas, 2017 .

Temozolomide in aggressive pituitary adenomas and carcinomas

B. Scheithauer, K. Kovacs, C. Fadul, 2012, Clinics.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells

J. Fisher, M. Ernstoff, C. Fadul, 2016, Melanoma research.

Recurrent meningioma

M. Chamberlain, C. Fadul, M. Glantz, 2007, Neurology.

A phase II trial of oral gimatecan for recurrent glioblastoma

P. Wen, C. Fadul, J. Supko, 2012, Journal of Neuro-Oncology.

Gene Expression Profile of Peripheral Blood Lymphocytes from Renal Cell Carcinoma Patients Treated with IL-2, Interferon-α and Dendritic Cell Vaccine

J. Gui, C. Tomlinson, J. Fisher, 2012, PloS one.

Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy

N. Wages, C. Fadul, 2019, Clinical trials.

Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.

H. Wishart, J. Gui, J. Kleen, 2015, Neuro-oncology.

The Neuroimmunology of Cancer

C. Fadul, W. Hickey, E. Lallana, 2011 .

Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma

Sohil H. Patel, D. Schiff, C. Fadul, 2019, Journal of Neuro-Oncology.

A clinical care pathway to improve the acute care of patients with glioma.

C. Fadul, Jennifer Hong, N. Riblet, 2016, Neuro-oncology practice.

A clinical care pathway to improve the acute care of patients with glioma.

C. Fadul, N. Kennedy, Jennifer A. Snide, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the quality of care for patients diagnosed with glioma during the perioperative period.

C. Fadul, K. Homa, N. Simmons, 2014, Journal of oncology practice.

Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis

C. Fadul, P. Batchala, P. Rehm, 2020, The neuroradiology journal.

Anti-VEGF therapy in pituitary carcinoma

B. Scheithauer, K. Kovacs, C. Fadul, 2012, Pituitary.

Safety Profile of Maintenance Obinutuzumab in Patients with Primary CNS Lymphoma in Complete Response

R. Strowd, D. Schiff, L. Junck, 2020 .

Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy

C. Eskey, E. Stommel, C. Fadul, 2005, Journal of Neuro-Oncology.

Agranulocytosis Associated with Lamotrigine in a Patient with Low‐grade Glioma

B. Jobst, C. Fadul, L. Lewis, 2002, Epilepsia.

Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines.

T. Tosteson, C. Fadul, B. Cole, 2009, Clinical colorectal cancer.

Palliative care education in U.S. adult neuro-oncology fellowship programs

C. Fadul, Natalie May, S. Verga, 2018, Journal of Neuro-Oncology.

A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the brain tumor investigational consortium (BTIC)

S. Rosenfeld, S. Phuphanich, M. Chamberlain, 2014, Journal of Neuro-Oncology.

Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer.

C. Fadul, M. Bakitas, M. Bookbinder, 2011, Journal of pain and symptom management.

Dye Dilution Proliferation Assay: Application of the DDPA to Identify Tumor-Specific T Cell Precursor Frequencies in Clinical Trials

A. Givan, J. Fisher, M. Ernstoff, 2007, Immunological investigations.

Brain activation patterns associated with working memory in relapsing-remitting MS

A. Saykin, B. McDonald, H. Wishart, 2004, Neurology.

Predictors of duloxetine response in patients with oxaliplatin‐induced painful chemotherapy‐induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial – CALGB/alliance 170601

C. Shapiro, C. Loprinzi, C. Fadul, 2017, European journal of cancer care.

Systematic review of the management of brain metastases from hormone receptor positive breast cancer

C. Fadul, P. Dillon, Shirley Jusino, 2023, Journal of Neuro-Oncology.

Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes

C. Fadul, L. Kasper, J. Channon, 1995, Infection and immunity.

Seizure prognosis of patients with low-grade tumors

D. Roberts, R. Scott, B. Jobst, 2012, Seizure.

Nonconvulsive Status Epilepticus After Intravenous Contrast Medium Administration

P. Williamson, C. Fadul, J. Pipas, 1996, Epilepsia.

Obstructive sleep apnea syndrome in a patient with medulloblastoma.

M. Sateia, C. Fadul, G. Greenough, 1999, Neuro-oncology.

Chemotherapy induced neuropathy in clinical practice

C. Fadul, 2007 .

Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports

D W Roberts, A. Saykin, B. McDonald, 2003, Journal of neurology, neurosurgery, and psychiatry.

Working memory in multiple sclerosis: Relation of fMRI activation to lesion volume

James C. Ford, A. Saykin, H. Wishart, 2001, NeuroImage.

Cerebellar metastases: diagnostic and management considerations.

K. Misulis, C. Fadul, R. Wiley, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of verubulin (MPC-6827) for the treatment of subjects with recurrent glioblastoma naïve to treatment with bevacizumab.

L. Recht, S. Rosenfeld, J. Raizer, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of oral gimatecan in adults with recurrent glioblastoma.

P. Wen, C. Fadul, J. Supko, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stereotactic Radiosurgery With and Without Checkpoint Inhibition for Patients with Metastatic Non-Small Cell Lung Cancer to the Brain: A Matched Cohort Study

L. Hansen, J. Sheehan, C. Fadul, 2019, Neurosurgery.

Relevance of the Updated Recursive Partitioning Analysis (U-RPA) Classification in the Contemporary Care of Patients with Brain Metastases

J. Sheehan, C. Fadul, W. Novicoff, 2023, Cancers.

Cost of anaesthetic drugs and clinical budgeting.

C. Fadul, J. Posner, J. O'Higgins, 1987, British medical journal.

Letter to the editor

J. Fisher, M. Ernstoff, C. Fadul, 2014, Journal of Immunotherapy for Cancer.

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.

Jennie W. Taylor, A. Iafrate, D. Cahill, 2020 .

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Katrina H. Smith, P. Wen, E. Wong, 2014, Neuro-oncology.

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

C. Shapiro, C. Fadul, E. Paskett, 2013, JAMA.

Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma.

J. Fisher, M. Ernstoff, C. Fadul, 2009, Cancer letters.

Production of macrophage-activated killer cells for targeting of glioblastoma cells with bispecific antibody to FcγRI and the epidermal growth factor receptor

P. Wallace, C. Fadul, M. Fanger, 2000, Cancer Immunology, Immunotherapy.

FLAIR lesion volume in multiple sclerosis: Relation to processing speed and verbal memory

A. Saykin, H. Wishart, A. Mamourian, 2005, Journal of the International Neuropsychological Society.

Methotrexate encephalopathy: Two cases in adult cancer patients, who recovered with pathophysiologically based therapy

D. Pastel, C. Fadul, L. Lewis, 2017, SAGE open medical case reports.

Tumor pharmacokinetics and pharmacodynamics of the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma

Sohil H. Patel, D. Schiff, C. Fadul, 2019, Journal of Neuro-Oncology.